Donna Hallas discusses the Pfizer-BioNTech vaccine booster for children 5 to 11 years old

Article

Contemporary Pediatrics® Editorial Advisory Board member Donna Hallas shares her thoughts on the recent authorization of a Pfizer-BioNTech COVID-19 booster shot for children 5-11 years old.

In a video for Contemporary Pediatrics®, Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN, discussed the recent FDA amendment of the current emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine which is now authorizing a single booster dose for children 5-11 years old. The Booster will be available to children of this age at least 5 months after completing the primary vaccine series.

Recent Videos
Tina Tan, MD, comments on FDA expanded approval for MenQuadfi meningococcal disease vaccine
Tina Tan, MD, discusses impact of FDA's stricter COVID-19 vaccine policy for children
Jennifer Soung, MD reacts to FDA approval of roflumilast foam 0.3%
Suzanne Hollander, MS, RD, LDN, Senior Clinical Nutrition Specialist, Boston Children's Hospital | Image credit: Boston Children's
Jillian Cotter, MD
Decreasing antibiotics for acute otitis media and community acquired pneumonia, with Elysha Pifko, MD
Tina Tan, MD
Danielle Van Damme, DNP, CPNP-AC
Karen Y. Capusan, DNP, CPNP-PC
Related Content
© 2025 MJH Life Sciences

All rights reserved.